Maxim Group reissued their hold rating on shares of Helius Medical Technologies (NASDAQ:HSDT – Free Report) in a report issued on Wednesday, Marketbeat Ratings reports.
Helius Medical Technologies Stock Down 1.8 %
Helius Medical Technologies stock opened at $0.54 on Wednesday. The company’s fifty day simple moving average is $0.70 and its 200-day simple moving average is $1.62. Helius Medical Technologies has a 12 month low of $0.37 and a 12 month high of $9.50. The stock has a market cap of $1.60 million, a P/E ratio of -0.04 and a beta of 1.60.
Helius Medical Technologies (NASDAQ:HSDT – Get Free Report) last posted its quarterly earnings results on Monday, August 12th. The company reported ($0.64) EPS for the quarter, missing the consensus estimate of ($0.50) by ($0.14). Helius Medical Technologies had a negative net margin of 1,487.54% and a negative return on equity of 258.06%. The company had revenue of $0.18 million for the quarter. During the same quarter in the prior year, the company posted ($3.00) EPS.
Institutional Investors Weigh In On Helius Medical Technologies
Helius Medical Technologies Company Profile
Helius Medical Technologies, Inc, a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise.
Further Reading
- Five stocks we like better than Helius Medical Technologies
- How to Invest in the FAANG Stocks
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Stock Dividend Cuts Happen Are You Ready?
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- What Are Dividend Contenders? Investing in Dividend Contenders
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.